申请人:AMGEN INC.
公开号:US20140171406A1
公开(公告)日:2014-06-19
Compounds of Formula I are useful as antagonists of TRPM8. Such compounds are useful in treating a number of TRPM8 mediated disorders and conditions and may be used to prepare medicaments and pharmaceutical compositions useful for treating such disorders and conditions. Examples of such disorders include, but are not limited to, migraines and neuropathic pain. Compounds of Formula I have the following structure:
where the definitions of the variables are provided herein.
公式I的化合物可用作TRPM8的拮抗剂。这些化合物可用于治疗许多TRPM8介导的疾病和症状,并可用于制备用于治疗此类疾病和症状的药物和药物组合物。此类疾病的例子包括但不限于偏头痛和神经病性疼痛。公式I的化合物具有以下结构:其中变量的定义在此提供。